Internal Medicine, Rheumatology · Murrieta, CA
NPI
1689640856
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
39755 Murrieta Hot Springs Rd, Suite F110
Murrieta, CA, 92563
Phone (951) 696-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
152,094 services
Medicare patients, 2024
694
Average age 74
Drug cost, 2024
$5.5M
8,386 prescriptions
Company payments, 2025
$11K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brigid M Freyne was code J3111 (injection, romosozumab-aqqg, 1 mg), 43,470 times for 39 patients. In total Brigid M Freyne billed 152,094 services in 89 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 43,470 | 39 | $8.58 | $373K |
| J0897 Injection, denosumab, 1 mg | Office | 16,860 | 172 | $20.59 | $347K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,300 | 12 | $9.09 | $94K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,550 | 12 | $33.83 | $222K |
| J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 5,225 | 33 | $4.16 | $22K |
| 99214 Office E&M - Established | Office | 2,013 | 580 | $100.15 | $202K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,521 | 25 | $0.10 | $153 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,242 | 272 | $47.03 | $58K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,091 | 405 | $13.38 | $15K |
| 86235 Immunoassay | Office | 987 | 138 | $17.34 | $17K |
| 96401 Chemotherapy Administration | Office | 871 | 210 | $63.91 | $56K |
| 99213 Office E&M - Established | Office | 849 | 209 | $71.91 | $61K |
| 36415 Venipuncture Blood Collection | Office | 759 | 491 | $8.62 | $6,541 |
| 76882 Ultrasound - Nonspecific | Office | 637 | 195 | $53.32 | $34K |
| 82306 Clinical Chemistry | Office | 523 | 444 | $28.69 | $15K |
By year: 2022 $2.2M for 156,798 services; 2023 $2.4M for 158,094 services; 2024 $2.3M for 152,094 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 987 | 138 | $17.34 | $17K |
| 36415 Venipuncture Blood Collection | 759 | 491 | $8.62 | $6,541 |
| 82306 Clinical Chemistry | 523 | 444 | $28.69 | $15K |
| 83516 Immunoassay | 254 | 125 | $11.22 | $2,850 |
| 86225 Immunoassay | 142 | 139 | $13.29 | $1,888 |
| 86226 Immunoassay | 141 | 138 | $11.71 | $1,652 |
| 86431 Immunoassay | 127 | 125 | $5.52 | $701 |
| 86200 Immunoassay | 122 | 121 | $12.60 | $1,537 |
| 86481 Immunoassay | 73 | 68 | $98.00 | $7,154 |
| 86376 Immunoassay | 14 | 14 | $13.24 | $185 |
Medicare prescription drug claims, 2024
In 2024, the drug Brigid M Freyne prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 482 prescriptions and refills. In total Brigid M Freyne wrote 8,386 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 482 | 1,006 | 131 | $14K |
| Hydroxychloroquine Sulfate Generic | 463 | 885 | 118 | $18K |
| Alendronate Sodium Generic | 390 | 948 | 134 | $3,618 |
| Prednisone Generic | 373 | 532 | 89 | $2,785 |
| Levothyroxine Sodium Generic | 368 | 873 | 108 | $5,102 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 360 | 362 | 49 | $7,254 |
| Allopurinol Generic | 293 | 725 | 68 | $2,616 |
| Tramadol Hcl Generic | 273 | 279 | 70 | $2,166 |
| Gabapentin Generic | 246 | 503 | 74 | $4,359 |
| Cyclobenzaprine Hcl Generic | 208 | 284 | 73 | $3,994 |
| Meloxicam Generic | 179 | 276 | 62 | $758 |
| Duloxetine Hcl Generic | 175 | 389 | 46 | $4,219 |
| Losartan Potassium Generic | 140 | 332 | 47 | $1,762 |
| Amlodipine Besylate Generic | 139 | 315 | 38 | $876 |
| Lisinopril Generic | 133 | 299 | 38 | $657 |
Brand drugs: 1,133 claims; generic drugs: 7,236 claims; opioid claims: 973.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brigid M Freyne $11K ($11K in general payments such as food, travel and fees) from 28 companies. The largest payer was Amgen Inc. with $3,385.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 47 | $3,385 |
| Sobi, Inc SOBI.ST | 4 | $2,642 |
| Janssen Biotech, Inc. JNJ | 49 | $992 |
| Mallinckrodt Hospital Products Inc. | 21 | $637 |
| UCB, Inc. UCB.BR | 17 | $532 |
| ANI Pharmaceuticals, Inc. ANIP | 25 | $506 |
| Abbvie Inc. ABBV | 14 | $318 |
| Pfizer Inc. PFE | 11 | $266 |
| Radius Health, Inc. | 11 | $247 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $230 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.